Gardner, J., & Webster, A. (2017). Tensions in the creation of biovalue: The Cell and Gene Therapy Catapult as an innovation accelerator agency. Science, Technology & Human Values.
Gardner, J., & Webster, A. (2016). The Social Management of Biomedical Novelty: Facilitating translation in regenerative medicine, Social Science and Medicine, vol 156:90-97.doi:10.1016/j.socscimed.2016.03.025
Mahalatchimy, A. (2016). Accreditation and regulations in cell therapy, ISBT Science Series (2016) 11 (Suppl. 1), 271–276.
Mahalatchimy, A. (2016). The reimbursement of cell- based regenerative therapy in the UK and France, The Medical Review.
Autologous vs allogeneic cell based regenerative therapies (PDF , 102kb)
Profiling characteristics of the RM reimbursement publications landscape (PDF , 1,051kb)
Clinical trials and the challenge of regenerative medicine (PDF , 142kb)
RegMedPoster_Inst readiness (PDF , 533kb)